4001 - 4050 of 9038 Results
Title
Year
-
OPENTitle: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanomaJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 15Start Page: eadq2519End Page: eadq2519Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adq2519Best OA location URL: https://doi.org/10.1126/sciadv.adq2519Citation Count: 6
-
OPENTitle: Transcriptomic responses of lung mesenchymal cells during pneumoniaJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.177084Best OA location URL: https://doi.org/10.1172/jci.insight.177084Citation Count: 3
-
OPENTitle: The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystoniaJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 134Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci177833Best OA location URL: https://doi.org/10.1172/jci177833Citation Count: 17
-
OPENTitle: Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neuronsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 6Start Page: eadj4767End Page: eadj4767Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adj4767Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adj4767?download=trueCitation Count: 15
-
OPENTitle: Three-step docking by WIPI2, ATG16L1, and ATG3 delivers LC3 to the phagophoreJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 6Start Page: eadj8027End Page: eadj8027Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adj8027Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adj8027?download=trueCitation Count: 34
-
OPENTitle: Improving Dysarthric Speech Segmentation With Emulated and Synthetic AugmentationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 382End Page: 389Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3375323Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/10464345.pdfCitation Count: 14
-
OPENTitle: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 284End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12915Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12915Citation Count: 20
-
OPENTitle: A comprehensive cognitive analysis of cervical dystonia: A single centre studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100226End Page: 100226Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100226Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100226Citation Count: 3
-
OPENTitle: Model-Based Comparison of Deep Brain Stimulation Array Functionality with Varying Number of Radial Electrodes and Machine Learning Feature SetsJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2016.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2016.00058/pdfCitation Count: 42
- Valbenazine as treatment for Huntington's disease chorea2023RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 5
- Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies2017RESTRICTEDTitle: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesJournal Name: Clinica Chimica ActaPublisher: Elsevier BVVol: 466Issue #:Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010Citation Count: 30
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 37
-
OPENTitle: Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 23Issue #:Start Page: 101824End Page: 101824Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101824Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101824Citation Count: 63
-
OPENTitle: δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s diseaseJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 2Start Page: 586End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0286-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6684859Citation Count: 83
-
OPENTitle: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometryJournal Name: Analytica Chimica ActaPublisher: Elsevier BVVol: 1154Issue #:Start Page: 338259End Page: 338259Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.aca.2021.338259Best OA location URL: https://doi.org/10.1016/j.aca.2021.338259Citation Count: 34
-
OPENTitle: Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom BurdenJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1679End Page: 1687Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29507Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10524668/pdf/nihms-1904753.pdfCitation Count: 6
-
OPENTitle: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort studyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 789End Page: 804Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251330993Best OA location URL: https://doi.org/10.1177/1877718x251330993Citation Count: 1
-
OPENTitle: Reinforcing properties of Pramipexole in normal and parkinsonian ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 49Issue #:Start Page: 79End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005Best OA location URL: https://doaj.org/article/f2c79dbe00db45cd8b639599d5d6db7fCitation Count: 37
-
OPENTitle: CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.70367Best OA location URL: https://doi.org/10.1002/acn3.70367Citation Count: 0
-
OPENTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page: eaba1193End Page: eaba1193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 70
-
OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 163
-
OPENTitle: α-synuclein Imaging: A Critical Need for Parkinson's Disease ResearchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 3Issue #: 4Start Page: 565End Page: 567Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130247Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130247?id=journal-of-parkinsons-disease%2Fjpd130247Citation Count: 81
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 69
- Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)2019RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
-
OPENTitle: Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicityJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 195Issue #:Start Page: 119034End Page: 119034Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopha.2026.119034Best OA location URL: https://doi.org/10.1016/j.biopha.2026.119034Citation Count: 0
-
OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 44
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 70
- Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms2018RESTRICTEDTitle: Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 126End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.004Citation Count: 55
-
OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 21
- Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case series2024RESTRICTEDTitle: Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case seriesJournal Name: International Journal of Speech-Language PathologyPublisher: Informa UK LimitedVol: 27Issue #: 2Start Page: 205End Page: 220Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17549507.2024.2330538Citation Count: 7
-
OPENTitle: Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 34Issue #:Start Page: 15End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5222688Citation Count: 40
- Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice2015RESTRICTEDTitle: Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned miceJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 586End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.032Citation Count: 18
- Association Between Pathology and Electroencephalographic Activity in Parkinson’s Disease2017RESTRICTEDTitle: Association Between Pathology and Electroencephalographic Activity in Parkinson’s DiseaseJournal Name: Clinical EEG and NeurosciencePublisher: SAGE PublicationsVol: 49Issue #: 5Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1550059417696179Citation Count: 11
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://doi.org/10.17863/cam.52302Citation Count: 4
-
OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: http://doi.org/10.1016/j.nbd.2014.10.016Citation Count: 158
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Citation Count: 12
-
OPENTitle: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liabilityJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 15Start Page: 2641End Page: 2646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034Best OA location URL: https://doi.org/10.7270/q2dr2z5hCitation Count: 14
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 18
-
RESTRICTEDTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006Citation Count: 532
-
OPENTitle: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in MiceJournal Name: EBioMedicinePublisher: Elsevier BVVol: 29Issue #:Start Page: 13End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdfCitation Count: 31
-
OPENTitle: Identification of small molecules that bind to the mitochondrial protein mitoNEETJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 21Start Page: 5350End Page: 5353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219Citation Count: 40
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 429
-
OPENTitle: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s DiseaseJournal Name: eneuroPublisher: Society for NeuroscienceVol: 8Issue #: 4Start Page: ENEURO.0559End Page: 20.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021Best OA location URL: https://www.eneuro.org/content/eneuro/8/4/ENEURO.0559-20.2021.full.pdfCitation Count: 14
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 10
- Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)2017RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
- Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)2020RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
-
OPENTitle: Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine ChallengeJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 93Issue #: 12Start Page: 1089End Page: 1098Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2022.10.012Citation Count: 83
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2